Literature DB >> 21903346

Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.

Sandeep Mannava1, Johannes F Plate, Austin V Stone, Thomas L Smith, Beth P Smith, L Andrew Koman, Christopher J Tuohy.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21903346     DOI： 10.1016/j.jhsa.2011.07.011

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN： 0363-5023            Impact factor:   2.230


× No keyword cloud information.
  4 in total

Review 1.  [Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].

Authors:  M Frerix; F M P Meier; W Hermann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

2.  Novel Uses for Botulinum Neurotoxin in Upper Limb Surgery.

Authors:  C W Metcalfe; S Naji; P McArthur
Journal:  J Hand Microsurg       Date:  2014-09-13

3.  Treatment of Raynaud's phenomenon with botulinum toxin type A.

Authors:  Xiaolong Zhang; Yong Hu; Zhiyu Nie; Ye Song; Yougui Pan; Ying Liu; Lingjing Jin
Journal:  Neurol Sci       Date:  2015-01-24       Impact factor: 3.307

4.  The mechanism of botulinum A on Raynaud syndrome.

Authors:  Yanwen Zhou; Ying Liu; Yunhua Hao; Ya Feng; Lizhen Pan; Wuchao Liu; Bing Li; Libin Xiao; Lingjing Jin; Zhiyu Nie
Journal:  Drug Des Devel Ther       Date:  2018-06-26       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.